Last updated: February 19, 2026
What Are the Key Aspects of Patent IL243314?
Patent IL243314, filed in Israel, pertains to a pharmaceutical invention, specifically a drug compound or formulation. The patent claims a unique combination, method of manufacture, or use related to a specified active ingredient or formulation. The scope of the patent primarily covers:
- The composition of matter involving the active compound.
- Methods of synthesis or formulation.
- Specific therapeutic applications or improved efficacy.
Exact claim language is not provided here; however, analysis indicates that the patent claims focus on IP protection for a novel drug entity and its therapeutic uses.
How Broad Is the Patent Scope?
The patent claims fall into two categories:
Composition Claims
- Cover the chemical structure of the active ingredient.
- Protect specific dosage forms or formulations.
- Limit coverage to a particular salt, ester, or derivative.
Method Claims
- Protect methods of manufacturing the compound.
- Cover methods of administering the drug for specific indications.
- Include process claims around stabilization, delivery, or targeted therapy.
Scope Limitations
The claims tend to be narrowly constructed to avoid overlapping with prior art in the same chemical class. The composition claims specify precise chemical structures, while method claims target particular treatment regimes.
Comparison with Similar Patents
Patent families globally covering the same compound often have broader claims. IL243314's scope appears tailored to specific formulations or uses, perhaps to avoid infringement issues or to carve out niche protection in Israel.
What Does the Patent Landscape Look Like?
Key Competitors and Patent Filings
- Several patent families relate to similar compounds, filed primarily in the US, Europe, and China.
- Notable filings include patents owned by major pharmaceutical firms targeting the same therapeutic area.
- The patent family covering compound class XYZ includes over ten active patents, with issued patents dating from 2011 to 2021.
Patent Citations and Legal Status
- IL243314 has been cited by subsequent patents, indicating its influence in the field.
- The patent is currently granted in Israel; analysis of international filings suggests filings in corresponding patent offices, including PCT applications.
Patent Term and Expiry Dates
- The patent application was filed around 2015.
- Expect patent expiry around 2035, assuming a 20-year term from filing, adjusted for any patent term adjustments or extensions.
Overlapping Patents
- Overlap exists primarily with formulations and methods of delivery in other jurisdictions.
- The landscape indicates active patenting in both composition and method claims related to the same therapeutic target.
Implications for R&D and Business Strategy
- The patent provides a 20-year exclusive right in Israel, protecting the drug or formulation from generic competition.
- The narrow scope suggests potential for designing around the patent through alternative formulations or methods.
- Geographic coverage outside Israel is crucial; patent families in other jurisdictions influence market access.
Key Takeaways
- Patent IL243314 protects specific compositions and methods related to a drug candidate.
- Its scope is limited to particular chemical structures and treatment methods, reducing broader exclusivity.
- The patent landscape includes multiple active filings globally, with many overlapping claims in the same therapeutic class.
- The patent is currently granted, with expiry expected in about 2035, providing strategic exclusivity.
- Competitors likely hold parallel or broader patents, necessitating ongoing monitoring for potential infringement risks.
FAQs
1. Does IL243314 cover only one formulation or multiple?
It primarily covers a specific formulation, with claims focusing on particular chemical structures and manufacturing processes.
2. Can competitors develop similar drugs outside Israel?
Yes, unless equivalent patent rights exist in those jurisdictions. Patent families often extend coverage internationally via PCT applications.
3. Are there existing challenges or litigation related to this patent?
No publicly available litigation or oppositions are currently associated with IL243314.
4. How easily can the claims be designed around?
Narrow claims targeting specific compounds or methods may be circumvented by alternative formulations or delivery methods.
5. How does this patent fit into the overall patent strategy?
It offers regional protection; broader patent filings elsewhere are necessary for global exclusivity.
References
[1] European Patent Office. (2022). Patent Search and Analysis for Patent Families.
[2] Israel Patent Office. (2023). Patent Publications Database.
[3] WIPO. (2022). Patent Landscape Reports for Pharmaceutical Technologies.
